Literature DB >> 3567877

Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma.

H Christiansen, F Franke, C R Bartram, S Adolph, B Rudolph, J Harbott, A Reiter, F Lampert.   

Abstract

Chromosome analyses including in situ hybridization with the protooncogene N-myc were carried out at diagnosis and several times at relapse in the bone marrow cells of a girl with disseminated neuroblastoma (stage IV) at ages 9, 23, 24, and 26 months, respectively. The tumor karyotype was pseudodiploid exhibiting partial monosomy for the short arm of chromosome #1, an aberration of the short arm of chromosome #2, and double minutes at diagnosis. Further structural aberrations of chromosomes #4, #6, and #17, and homogeneously staining regions could be demonstrated at relapse. In particular, the following structural aberrations were encountered: t(1;?)(p22;?),t(2;?)(p24;?), t(4;6)(q31;q25), and a der(17q). All tumor metaphases without homogeneously staining regions contained double minutes. N-myc, normally positioned within bands 2p23-24, was found to be amplified in a homogeneously staining region on the short arm of chromosome #15 by in situ hybridization. It is speculated that the translocation t(2;?)(p24;?) might be related to N-myc oncogene activation and subsequent amplification.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567877     DOI: 10.1016/0165-4608(87)90057-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Uptake and release of iodine-labelled m-iodobenzylguanidine in a neuroblastoma cell culture system and its importance in neuroblastoma therapy.

Authors:  V Paffenholz; U Ebener; B Kornhuber
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.

Authors:  L Longo; H Christiansen; N M Christiansen; P Cornaglia-Ferraris; F Lampert
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.

Authors:  H Christiansen; F Lampert
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

4.  Association of cytogenetic abnormalities in a neuroblastoma and fragile sites expression.

Authors:  P Vernole; C Concato; C Pianca; B Nicoletti; G Melino
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.